Tura, A., Pawlik, V. E., Rudolf, M., Ernesti, J. S., Stutzer, J., Grisanti, S., & Ranjbar, M. (2019). Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities. Cancers (Basel).

Tura, Aysegül, Vera E. Pawlik, Martin Rudolf, Justus S. Ernesti, Jan-Niklas Stutzer, Salvatore Grisanti, i Mahdy Ranjbar. "Uptake of Ranibizumab but Not Bevacizumab Into Uveal Melanoma Cells Correlates With a Sustained Decline in VEGF-A Levels and Metastatic Activities." Cancers (Basel) 2019.

Tura, Aysegül, et al. "Uptake of Ranibizumab but Not Bevacizumab Into Uveal Melanoma Cells Correlates With a Sustained Decline in VEGF-A Levels and Metastatic Activities." Cancers (Basel) 2019.